Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector

Mechanisms of Ageing and Development

Volumn 128, Issue 4, 2007, Pages 311-316

  Hayakawa, Natsumi ^a   Kato, Hiroyuki ^b   Araki, Tsutomu ^a  

^a Graduate School of Pharmaceutical Sciences   (Japan)

^b INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Ageing; Astrocyte; Hippocampal CA1 sector; Immunohistochemistry; Mice; Microglia; Oligodendrocyte

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MOUSE; NONHUMAN; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

AGING; ANIMALS; ASTROCYTES; HIPPOCAMPUS; MALE; MICE; MICE, INBRED ICR; MICROGLIA; OLIGODENDROGLIA;

MUS;

EID: 34247174374     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2007.01.005     Document Type: Article

References (50)

1. Barnes C.A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 93 (1979) 74-104
2. Barnes C.A. Aging and the physiology of spatial memory. Neurobiol. Aging 9 (1988) 563-568
3. Bjorklund H., Eriksodotter-Nilsson M., Dahl D., Rose G., Hoffer B., and Olson L. Image analysis of GFA-positive astrocytes from adolescence to senescence. Exp. Brain Res. 58 (1985) 163-170
4. Calhoun M.E., Kurth D., Phinney A.L., Long J.M., Hengemihle J., Mouton P.R., Ingram D.K., and Jucker M. Hippocampal neurons and synaptophysin-positive button number in aging C57Bl/6 mice. Neurobiol. Aging 19 (1998) 599-606
5. David J.P., Ghozali F., Fallet-Bianco C., Wattez A., Delaine S., Boniface B., Di Menza C., and Delacourte A. Glial reaction in the hippocampal formation is highly correlated with aging in human brain. Neurosci. Lett. 235 (1997) 53-56
6. deToledo-Morrell L., Geinisman Y., and Morrell F. Age-dependent alterations in hippocampal synaptic plasticity: relation to memory disorders. Neurobiol. Aging 9 (1988) 581-590
7. Eichenbaum H. The hippocampus and declarative memory: cognitive mechanisms and neural codes. Behav. Brain Res. 127 (2001) 199-207
8. Felzien L.K., McDonald J.T., Gleason S.M., Berman N.E., and Klein R.M. Increased chemokine gene expression during aging in the murine brain. Brain Res. 890 (2001) 137-146
9. Finch C.E. Neurons, glia, and plasticity in normal brain aging. Adv. Gerontol. 10 (2002) 35-39
10. Gallagher M., and Nicolle M.M. Animal models of normal aging: relationship between cognitive decline and markers in hippocampal circuitry. Behav. Brain Res. 57 (1993) 155-162
11. Geinisman Y., Toledo-Morrell L., and Morrell F. Loss of perforated synapses in the dentate gyrus: morphological substrate of memory deficit in aged rats. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 3027-3031
12. Giulian D., Young D.G., Woodward J., Brown D.C., and Lachman L.B. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8 (1988) 709-714
13. Guttmann C.R., Jolesz F.A., Kikinis R., Killiany R.J., Moss M.B., Sandor T., and Albert M.S. White matter changes with normal aging. Neurology 50 (1998) 973-978
14. Hansen L.A., Armstrong D.M., and Terry R.D. An immunohistochemical quantification on fibrous astrocytes in the aging human cerebral cortex. Neurobiol. Aging 8 (1987) 1-6
15. Hartung H.P., Jung S., Stroll G., Zielasek J., Schmidt B., Archelos J.J., and Toyka K.V. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J. Neuroimmunol. 40 (1992) 197-210
16. Hilker R., Thiel A., Geisen C., and Rudolf J. Cerebral blood flow and glucose metabolism in multi-infarct-dementia related to primary anti-phospholipid antibody syndrome. Lupus 9 (2000) 311-316
17. Himeda T., Mizuno K., Kato H., and Araki T. Effects of age on immunohistochemical changes in the mouse hippocampus. Mech. Ageing Dev. 126 (2005) 673-677
18. Himeda T., Watanabe Y., Tounai H., Haykawa N., Kato H., and Araki T. Time dependent alterations of co-localization of S100beta and GFAP in the MPTP-treated mice. J. Neural Transm. 113 (2006) 1887-1894
19. Hisahara S., Okano H., and Miura M. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci. Res. 46 (2003) 387-397
20. Homburger F., Russfield A.B., Weisburger J.H., Lim S., Chak S.P., and Weisburger E.K. Aging changes in CD-1 HaM/ICR mice reared under standard laboratory conditions. J. Natl. Cancer Inst. 55 (1975) 37-45
21. Kato H., Kurosaki R., Oki C., and Araki T. Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice. Brain Res. 1030 (2004) 66-73
22. Kimelberg H.K., and Norenberg M.D. Astrocytes. Sci. Am. 260 (1989) 66-72
23. Kohama S.G., Gross J.R., Finch C.E., and McNeil T.H. Increases of glial fibrillary acidic protein in the aging female mouse brain. Neurobiol. Aging 16 (1995) 59-67
24. Landfield P.W. Hippocampal neurobiological mechanisms of age-related memory dysfunction. Neurobiol. Aging 9 (1988) 571-579
25. Laping N.J., Teter B., Nichols N.R., Rozovsky I., and Finch C.E. Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol. 4 (1994) 259-275
26. Li W.P., Chan W.Y., Lai H.W., and Yew D.T. Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J. Mol. Neurosci. 8 (1997) 75-82
27. Lintl P., and Braak H. Loss of intracortical myelinated fibers: a distinctive age-related alteration in the human striate area. Acta Neuropathol. 61 (1983) 178-182
28. Long J.M., Kalehua A.N., Muth N.J., Calhoun M.E., Jucker M., Hengemihle J.M., Ingram D.K., and Mouton P.R. Stereological analysis of astrocytes and microglia in aging mouse hippocampus. Neurobiol. Aging 19 (1998) 497-503
29. Melcangi R.C., Magnaghi V., Cavarretta I., Riva M.A., Piva F., and Martini L. Effects of steroid hormones on gene expression of glial markers in the central and peripheral nervous system: variations induced by aging. Exp. Gerontol. 33 (1998) 827-836
30. Mesulam M.M. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Neuron 24 (1999) 521-529
31. Miller D.B., and O'Callaghan J.P. Aging, stress and the hippocampus. Ageing Res. Rev. 4 (2005) 123-140
32. Molina-Holgado E., Vela J.M., Arevalo-Martin A., and Cuaza C. LPS/IFN-gamma cytotoxicity in oligodendroglial cells: role of nitric oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 13 (2001) 493-502
33. Mouton P.R., Long J.M., Lei D.L., Howard V., Jucker M., Calhoun M.E., and Ingram D.K. Age and gender effects on microglia and astrocyte numbers in brains of mice. Brain Res. 956 (2002) 30-35
34. Nichols N.R., Day J.R., Laping N.J., Johnson S.A., and Finch C.E. GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14 (1993) 421-429
35. O'Callaghan J.P., and Miller D.B. The concentration of glial fibrillary acidic protein increases with age in the mouse an rat brain. Neurobiol. Aging 12 (1991) 171-174
36. Perry V.H., Matyszak M.K., and Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia 7 (1993) 60-67
37. Peters A. Age-related changes in oligodendrocytes in monkey cerebral cortex. J. Comp. Neurol. 371 (1996) 153-163
38. Pilegaard K., and Ladefoged O. Total number of astrocytes in the molecular layer of the dentate gyrus of rats at different ages. Anal. Quant. Cytol. Histol. 18 (1996) 279-285
39. Rapp P.R., and Gallagher M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9926-9930
40. Schwartz M., Butovsky O., Bruck W., and Hanisch U.K. Microglial phenotype: is the commitment reversible?. Trends Neurosci. 29 (2006) 68-74
41. Sheffield L.G., and Berman N.E. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol. Aging 19 (1998) 47-55
42. Sloane J.A., Hollander W., Rosene D.L., Moss M.B., Kemper T., and Abraham C.R. Astrocytic hypertrophy and altered GFAP degradation with age in subcortical white matter of the rhesus monkey. Brain Res. 862 (2000) 1-10
43. Streit W.J. Microglia and neuroprotection: implications for Alzheimer's disease. Brain Res. Rev. 48 (2005) 234-239
44. Tanaka J., Okuma Y., Tomobe K., and Nomura Y. The age-related degeneration of oligodendrocytes in the hippocampus of the senescence-accelerated mouse (SAM)P8: a quantitative immunohistochemical study. Biol. Pharm. Bull. 28 (2005) 615-618
45. Vlkolinsky R., Cairns N., Fountoulakis M., and Lubec G. Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol. Aging 22 (2001) 547-553
46. Watanabe H., Muramatsu Y., Kurosaki R., Michimata M., Matsubara M., Imai Y., and Araki T. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neuotoxicity: an immunohistological study. Eur. Neuropsychopharmacol. 14 (2004) 93-104
47. West M.J. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol. Aging 14 (1993) 287-293
48. West M.J., Kawas C.H., Stewart W.F., Rudow G.L., and Troncoso J.C. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol. Aging 25 (2004) 1205-1212
49. Wickelgren I. Is hippocampal cell death a myth?. Science 271 (1996) 1229-1230
50. Wu Y., Zhang A.Q., and Yew D.T. Age related changes of various markers of astrocytes in senescence-accelerated mice hippocampus. Neurochem. Int. 46 (2005) 565-574